Current Challenges and Future Opportunities in the BK Virus (BKV) Infection Market
BK virus infection is a serious health concern among organ transplant patients, as it can lead to nephropathy and graft loss. BK virus, a type of human polyomavirus, usually remains dormant after primary infection but may reactivate after immunosuppression in transplant recipients. Once reactivated, it can cause BK virus-associated nephropathy (BKVAN) which occurs in 1-10% of kidney transplant recipients and results in graft loss in 50% of affected patients.
The virus also poses risks of rejecting heart, lung, liver and hematopoietic stem cell transplants. Detection and preemptive monitoring of BK Virus (BKV) Infection Market are important to manage the infection and avoid graft loss.
The BK Virus (BKV) infection market is estimated to be valued at USD 34 Mn in 2024 and is expected to reach USD 389 Mn by 2031, growing at a compound annual growth rate (CAGR) of 41.7% from 2024 to 2031.
Get more insights on: BK Virus (BKV) Infection Market
Get this Report in Japanese Language: BKウイルス（BKV）感染症市場
Get this Report in Korean Language: BK 바이러스(BKV) 감염 시장
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian